Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03674528 · ClinicalTrials.gov registry record
Technical Validation of MR Biomarkers of Obesity-Associated NAFLD
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 152
- Enrollment target
NCT03674528: Completed study, sponsored by University of Wisconsin, Madison.
NCT03674528 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 152 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03674528 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 152 participants
- Enrollment target
Study Summary
The overall goal of this collaborative research program is to develop, validate and translate advanced quantitative magnetic resonance (MR) biomarkers of obesity-associated non-alcoholic fatty liver disease (NAFLD). This protocol represents the research plan for two distinct phases. The first phase is an optimization phase. The second phase is designed to complete a rigorous test of conventional and advanced MRE techniques. Complementary anthropometric, laboratory, and MR measures will also be collected to characterize the cohort and identify factors that affect MRE performance
Primary Outcome
Optimize MRE wave-field generation in this subject population to maximize the area of invertible shear waves in the liver into interpretable shear stiffness maps.
Interventions
- DIAGNOSTIC_TEST Liver biopsy
- OTHER Magnetic Resonance Elastography (MRE)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2018-05-04 |
| Est. Completion | 2024-06-11 |
What the finished NCT03674528 record still lists
NCT03674528 is an observational study that tracks outcomes without assigning an intervention. The registered 152 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Liver biopsy is the first listed.
NCT03674528 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03674528 about?
NCT03674528 is a clinical study titled "Technical Validation of MR Biomarkers of Obesity-Associated NAFLD". The overall goal of this collaborative research program is to develop, validate and translate advanced quantitative magnetic resonance (MR) biomarkers of obesity-associated non-alcoholic fatty liver disease (NAFLD). This protocol represents the research plan for two distinct phases. The first phase ...
What is the current status of trial NCT03674528?
This trial is currently completed. The enrollment target is 152 participants. The study started on 2018-05-04. Estimated completion is 2024-06-11.
What interventions are being tested in trial NCT03674528?
The interventions under investigation include: Liver biopsy (DIAGNOSTIC_TEST), Magnetic Resonance Elastography (MRE) (OTHER).
Who is sponsoring clinical trial NCT03674528?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03328078 · 152 participants · Phase 1
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- NCT04458532 · 152 participants · NA
Exercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Early Stage Breast Cancer
- NCT04858334 · 152 participants · Phase 2
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
- NCT04993859 · 152 participants
Impact of Chemotherapy on Urinary Biomarkers and Non-Invasive Urodynamics in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI